News / Stock

Opiates. Indivior accused of fraud for Suboxone prescriptions. Alphie reviews the sector

Apr 11, 2019 - 16:30 GMT+0200

Shares of the drug manufacturer Indivior have dropped more than 70% after the US Department of Justice charged with fraudulent marketing. It seems that the company has carried out a program to increase sales of its drug Suboxone, used for the treatment of opioid addiction. The applied system, called “Here to Help”, provided for the referral of dependent patients to doctors willing to prescribe the drug beyond the limits imposed by federal law. The DoJ requested a fine of $ 3 billion, while Indivior challenged all charges. This indictment comes at a time when many opiate drug companies, including Purdue…

Register to continue reading for free